Use of Fibroquel® (Polymerized type I collagen) in patients with hypoxemic inflammatory pneumonia secondary to COVID-19 in Veracruz, Mexico
- Journal of Anesthesia & Critical Care: Open Access
-
Luis Del Carpio-Orantes, Sergio García-Méndez, Jesús Salvador Sánchez-Díaz, Andrés Aguilar-Silva, Edna Rosario Contreras-Sánchez, Sara Nohemí Hernández-Hernández
Abstract
Since the beginning of the pandemic, there is currently no specific treatment, however some drugs, after systematic reviews and meta-analysis have been positioned as potential treatments (dexamethasone, tocilizumab, baricitinib), however, other drugs with therapeutic potential are being investigated, such as Polymerized type I collagen (Fibroquel).
Keywords
Polymerized type I collagen, Fibroquel, Pneumonia, COVID-19
